X4 Pharmaceuticals, Inc (XFOR) stock
Close on Nov 13, 2026Market cap $309.34MP/E –Yield –
X4 Pharmaceuticals statistics
74 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 2.85
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 12.29
- 2.57
Share statisticsIndustry
- Shares Change (QoQ)
- 4.98%
- 0.50%
- Float
- 87M
- 49M
- Shares Held by Insiders
- 12.2%
- 11.7%
- Shares Held by Institutions
- 103.0%
- 56.4%
Short sellingIndustry
- Short Interest
- 8M
- –
- Short Interest Change
- 6.45%
- -0.80%
- Short % of Float
- 9.16%
- 9.01%
- Short % of Shares Outstanding
- 8.04%
- 6.30%
- Days to Cover
- 10.86
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $4.83
- –
- 52-Week Low
- $2.43
- –
- 20-Day Moving Average
- $3.19
- –
- 50-Day Moving Average
- $3.15
- –
- 200-Day Moving Average
- $3.78
- –
- Average True Range (14)
- $0.24
- –
- Price Change (1 Week)
- -1.89%
- -1.15%
- Price Change (1 Month)
- 18.2%
- -4.87%
- Price Change (3 Months)
- -27.4%
- -21.0%
- Price Change (6 Months)
- -20.8%
- -20.6%
- Price Change (YTD)
- -22.0%
- -23.6%
- Price Change (1 Year)
- -19.4%
- -22.4%
- Price Change (3 Years)
- -86.9%
- -29.5%
- Price Change (5 Years)
- -97.9%
- -77.9%
- Average Volume (10 Days)
- 762,513
- –
- Average Volume (20 Days)
- 741,051
- –
- Average Volume (90 Days)
- 809,012
- –
- Relative Volume
- 0.62
- 0.70
- Relative Strength Index (14)
- 47.8
- 43.4
- Volatility (1 Year)
- 71.5%
- 80.1%
- Beta (5 Years)
- 1.41
- 1.07
MarginsIndustry
- Pretax Margin
- -813.3%
- -11.6%
- EBITDA Margin
- -794.1%
- -27.7%
Returns on capitalIndustry
- Return on Equity (ROE)
- -80.3%
- -49.9%
- Return on Assets (ROA)
- -40.7%
- -40.6%
- Return on Capital Employed (ROCE)
- -37.1%
- -37.9%
Financial positionIndustry
- Current Ratio
- 13.22
- 3.30
- Quick Ratio
- 12.62
- 2.39
- Interest Coverage
- -9.26
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 73.7%
- 6.82%
- Revenue Growth (5Y CAGR)
- 16.7%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.05
- 0.40
- Revenue Per Employee
- $220.00K
- $429.29K
- Profits Per Employee
- -$1.79M
- -$689.41K
- Employee Count
- 45
- 74
- WACC
- 12.2%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$80.52M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $187.70M
- $17.76M
- Net Cash Per Share
- $1.89
- $0.80
- Equity (Book Value)
- $138.88M
- $53.89M
- Book Value Per Share
- $1.40
- $1.50
- Tangible Book Value
- $108.71M
- $27.13M
- Working Capital
- $183.15M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -26.0%
- -21.8%
Taxes and interestIndustry
- Interest Expense
- $8.68M
- $2.90M
- Income Tax
- $5.00K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -2.09
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | XFOR | S&P 500 | Difference | XFOR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +20.0% | -3.0% | +23.0 pts | ||
| 3 months | -27.3% | -2.8% | −24.5 pts | ||
| Year to date | -22.0% | +11.5% | −33.5 pts | ||
| 1 year | -16.4% | +13.5% | −29.8 pts | ||
| 3 years | -86.3% | +77.7% | −164.0 pts | -48.5% | +21.1% |
| 5 years | -97.9% | +72.6% | −170.5 pts | -53.7% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
8M XFOR shares were sold short on Oct 30, 2026, up 6.4% from the previous report, or 9.16% of the shares available to trade. At recent volumes it would take 10.9 days to buy them back. Over the last 20 sessions, 40.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 7,973,579 | +6.4% | 734,226 | 10.9 |
| Oct 15, 2026 | 7,490,770 | -1.3% | 599,106 | 12.5 |
| Sep 30, 2026 | 7,590,000 | -7.8% | 1,256,869 | 6.0 |
| Sep 15, 2026 | 8,236,475 | +14.6% | 1,164,513 | 7.1 |
| Aug 31, 2026 | 7,190,058 | +0.4% | 560,027 | 12.8 |
| Aug 14, 2026 | 7,164,662 | -1.9% | 803,567 | 8.9 |
| Jul 31, 2026 | 7,300,120 | +12.3% | 572,776 | 12.8 |
| Jul 15, 2026 | 6,501,966 | +18.1% | 663,901 | 9.8 |
| Jun 30, 2026 | 5,507,057 | +31.7% | 1,586,041 | 3.5 |
| Jun 15, 2026 | 4,180,487 | +24.0% | 421,393 | 9.9 |
| May 29, 2026 | 3,371,418 | +15.3% | 363,115 | 9.3 |
| May 15, 2026 | 2,923,580 | -6.2% | 344,226 | 8.5 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?